Our data also demonstrated the antidepressant properties of oltipraz in neuropathic pain, which may be mediated via inhibiting microglial activation in the hippocampus and triggering the Nrf2/HO-1/NQO1 signaling pathway in the prefrontal cortex and/or hippocampus. The gene discussed is HMOX1; the disease is neuropathic pain.